105
Views
17
CrossRef citations to date
0
Altmetric
Research Article

The Role of DNA Hypermethylation in the Pathogenesis and Prognosis of Acute Lymphoblastic Leukemia

, , , , &
Pages 1855-1864 | Published online: 01 Jul 2009

References

  • Pui, C-H. and Evans,W.E. (1998) "Acute lymphoblastic leukemia", N. Engl. J. Med. 339, 605–615.
  • Pui, C-H., Behm, F.G. and Crist, W.M. (1993) "Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia", Blood 82, 343–362.
  • Ponder, B.A.J. (2001) "Cancer genetics", Nature 411, 336–341.
  • Pui, C-H., Crist, W.M. and Look, A.T. (1990) "Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia", Blood 76, 1449–1463.
  • Faderl, S., Kantarjian, H.M., Talpaz, M. and Estrov, Z. (1998) "Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia", Blood 91, 3995–4019.
  • Wada, M., Bartram, C.R., Nakamura, H., Hachiya, M., Chen, D.L., Borenstein, J., Miller, C.W., Ludwig, L., Hansen-Hagge, T.E. and Ludwib,W.D. (1993) "Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood", Blood 82, 3163–3169.
  • Jones, P.A. and Laird, P.W. (1999) "Cancer epigenetics comes of age", Nat. Genet. 21, 163–167.
  • Wolffe, A.P. and Matzke, M.A. (1999) "Epigenetics: regulation through repression", Science 286, 481–486.
  • Tycko, B. (2000) "Epigenetic gene silencing in cancer", J. Clin. Investig. 105, 401–407.
  • Jones, P.A. and Baylin, S.B. (2002) "The fundamental role of epigenetic events in cancer", Nat. Rev. Genet. 3, 415–428.
  • Baylin, S.B. and Herman, J.G. (2000) "DNA hypermethylation in tumorigenesis: epigenetics joints genetics", Trends Genet. 16, 168–174.
  • Mompaler, R.L. and Bovenzi, V. (2000) "DNA methylation and cancer", J. Cell. Physiol. 183, 145–154.
  • Costello, J.F. and Plass, C. (2001) "Methylation matters", J. Med. Genet. 38, 285–303.
  • Bird, A. (2002) "DNA methylation patterns and epigenetic memory", Genes Dev. 16, 6–21.
  • Li, E., Bestor, T.H. and Jaenisch, R. (1992) "Targeted mutation of the DNA methyltransferase gene results in embryonic lethality", Cell 69, 915–926.
  • Okano, M., Bell, D.W., Haber, D.A. and Li, E. (1999) "DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development", Cell 99, 247–257.
  • Yoder, J.A., Walsh, C.P. and Bestor, T.H. (1997) "Cytosine methylation and the ecology of intragenomic parasites", Trends Genet. 13, 335–340.
  • Bird, A.P. (1986) "CpG-rich islands and the function of DNA methylation", Nature 321, 209–213.
  • Tycko, B. (1997) "DNA methylation in genomic imprinting", Mutat. Res. 386, 131–140.
  • Goto, T. and Monk, M. (1998) "Regulation of X-chromosome inactivation in development in mice and humans", Microbiol. Mol. Biol. Rev. 62, 362–378.
  • De Smet, C., Lurquin, C., Lethe, B., Martelange, V. and Boon, T. (1999) "DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter", Mol. Cell. Biol. 19, 7327–7335.
  • Torres, L., Lopez-Rodas, G., Latasa, M.V., Carretero, M.V., Rodriguez, J.L., Franco, L., Mato, J.M. and Avila, M.A. (2000) "DNA methylation and histone acetylation of rat methionine adenosyltransferase 1A and 2A genes is tissue-specific", Int. J. Biochem. Cell. Biol. 32, 397–404.
  • Jones, A. (1985) "Altering gene expression with 5-azacytidine", Cell 40, 485–486.
  • Li, E., Beard, C. and Jaenisch, R. (1993) "Role for DNA methylation in genomic imprinting", Nature 366, 362–365.
  • Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. and Issa, J.P. (1998) "Alterations in DNA methylation: a fundamental aspect of neoplasia", Adv. Cancer Res. 72, 141–196.
  • Hendrich, B. and Bird, A. (2000) "Mammalian methyltransferases and methyl-CpG binding domains: proteins involved in DNA methylation", Curr. Top. Microbiol. Immunol. 249, 55–74.
  • Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, K.U., Landsberger, N., Stroboulis, J. andWolffe, A.P. (1998) "Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription", Nat. Genet. 19, 187–191.
  • Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. and Bird, A. (1998) "Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex", Nature 393, 386–389.
  • Rountree, M.R., Bachman, K.E., Herman, J.G. and Baylin, S.B. (2001) "DNA methylation, chromatin inheritance, and cancer", Oncogene 20, 3156–3165.
  • Mannervik, M., Nibu, Y., Zhang, H. and Levine, M. (1999) "Transcriptional coregulators in development", Science 284, 606–609.
  • Struhl, K. (1998) "Histone acetylation and transcriptional regulatory mechanisms", Genes Dev. 12, 599–606.
  • Pietenpol, J.A., Bohlander, S.K., Sato, Y., Papadopoulus, N., Liu, B., Friedman, C., Track, B.J., Roberts, J.M., Kinzler, K.W. and Powley, J.D. (1995) "Assignment of the human p27kip1 gene to 12p13 and its analysis in leukemias", Cancer Res. 55, 1206–1210.
  • Hsieh, C.L. (1994) "Dependence of transcriptional repression on CpG methylation density", Mol. Cell Biol. 14, 5487–5494.
  • Vertino, P.M., Yen, R.W., Grao, J. and Baylin, S.B. (1996) "De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5)-methyltransferase", Mol. Cell Biol. 16, 4555–4565.
  • Graff, J.R., Herman, J.G., Myohanen, S., Baylin, S.B. and Vertino, P.M. (1997) "Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation", J. Biol. Chem. 272, 22322–22329.
  • Myohanen, S.K., Baylin, S.B. and Herman, J.G. (1998) "Hypermethylation can selectively silence individual p16ink4a alleles in neoplasia", Cancer Res. 58, 591–593.
  • Esteller, M., Corn, P.G., Baylin, S.B. and Herman, J.G. (2001) "A gene hypermethylation profile of human cancer", Cancer Res. 61, 3225–3229.
  • Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) "50 CpG island hypermethylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers", Nat. Med. 1, 686–692.
  • Esteller, M., Hamilton, S.R., Burger, P.C., Baylin, S.B. and Herman, J.G. (1999) "Inactivation of the DNA repair gene O6-methylguanine- DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia", Cancer Res. 59, 793–797.
  • Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M.A., Baylin, S.B. and Herman, J.G. (2000) "Hypermethylationassociated inactivation of p14ARF is independent of p16INK4a methylation and p53 mutational status", Cancer Res. 60, 129–133.
  • Esteller, M., Sparks, A., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M.A., Gonzalez, S., Tarafa, G., Sidransky, D., Meltzer, S.J., Baylin, S.B. and Herman, J.G. (2000) "Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer", Cancer Res. 60, 4366–4371.
  • Rush, L.J. and Plass, C. (2002) "Alterations of DNA methylation in hematologic malignancies", Cancer Lett. 185, 1–12.
  • Chim, C.S., Liang, R. and Kwong, Y.L. (2002) "Hypermethylation of gene promoters in hematological neoplasia", Hematol. Oncol. 20, 167–176.
  • Shteper, P.J. and Ben-Yehuda, D. (2002) "Methylation of gene promoters in leukemogenesis", Isr. Med. Assoc. J. 4, 1066–1071.
  • Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C., Schuller, D.E., Yu, L., Bloomfield, C.D., Caligiuri, M.A., Yates, A., Nishikawa, R., Su, Huang, H., Petrelli, N.J., Zhang, X., O'Donisio, M.S., Held, W.A., Cavenee, W.K. and Plass, C. (2000) "Aberrant CpG-island methylation has non-random and tumour-type-specific patterns", Nat. Genet. 24, 132–138.
  • Leegwater, P.A., Lambooy, L.H., De Abreu, R.A., Bokkerink, J.P. and van den Heuvel, L.P. (1997) "DNA methylation patterns in the calcitonin gene region at first diagnosis and at relapse of acute lymphoblastic leukemia", Leukemia 11, 971–978.
  • Thomas, X., Teillon, M.H., Belhabri, A., Rimokh, R., Fiere, D., Magaud, J.P. and Archimbaud, E. (1999) "Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission", Hematol. Cell Ther. 41, 19–26.
  • Roman-Gomez, J., Castillejo, J.A., Jimenez, A., Gonzalez, M.G., Reina, M.L., Rodriguez, M.C., Bornstein, R., Maldonado, J. and Torres, A. (2001) "Hypermethylation of the calcitonin gene in acute lymphoblastic leukemia is associated with unfavourable clinical outcome", Br. J. Haematol. 113, 329–338.
  • Issa, J.P., Zehnbauer, B.A., Civin, C.I., Collector, M.I., Sharkis, S.J., Davidson, N.E., Kaufmann, S.H. and Baylin, S.B. (1996) "The estrogen receptor CpG island is methylated in most hematopoietic neoplasms", Cancer Res. 56, 973–977.
  • Batova, A., Diccianni, M.B., Yu, J.C., Nobori, T., Link, M.P., Pullen, J. and Yu, A.L. (1997) "Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia", Cancer Res. 57, 832–836.
  • Cameron, E.E., Baylin, S.B. and Herman, J.G. (1999) "P15INK4b CpG island methylation in primary acute leukemia is heterogeneous and suggests density as critical factor for transcription silencing", Blood 94, 2445–2451.
  • Wong, I.H., Ng, M.H., Huang, D.P. and Lee, J.C. (2000) "Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications", Blood 95, 1942–1949.
  • Nakamura, M., Sugita, K., Inukai, T., Goi, K., Iijima, K., Tezuka, T., Kojika, S., Shiraishi, K., Miyamoto, N., Karakida, K., O-Koyama, T., Mori, T. and Nakazawa, N. (1999) "P16/MTS1/INK4a gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation", Leukemia 13, 884–890.
  • Roman-Gomez, J., Castillejo, J.A., Jimenez, A., Gonzalez, M.G., Moreno, F., Rodriguez, M.C., Barrios, M., Maldonado, J. and Torres, A. (2002) "50 CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1gene and confers poor prognosis in acute lymphoblastic leukemia", Blood 99, 2291–2296.
  • Siraj, A.J., Gutierrez, M.I., Bhargava, M., Advani, S., Ozbek, V., Chaudhary, A.M., Solh, E.H. and Bhatia, K. (2002) "Analyses of concurrent hypermethylation of multiple genes identify E-cadherin as the most common epigenetic lesion in childhood ALL", Blood 100, 761a.
  • Garcia-Manero, G., Shen, L., Toyota, M., Kondo, Y., Obata, T., Daniel, S., Pierce, S., Imai, K., Kantarjian, H. and Issa, J-P. (2002) "Aberrant DNA methylation of a cell cycle regulatory pathway composed of p73, p15 and p57kip2 identifies adult patients with Philadelphia-chromosome negative acute lymphoblastic leukemia and poor prognosis", Blood 100, 755a.
  • Corn, P.G., Kuerbitz, S.J., van Noesel, M.M., Esteller, M., Compitello, N., Baylin, S.B. and Herman, J.G. (1999) "Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 50 CpG island methylation", Cancer Res. 59, 3352–3356.
  • Kawano, S., Miller, C.W., Gombart, A.F., Bartram, C.R., Matsuo, Y., Asou, H., Sakashita, A., Said, J., Tatsumi, E. and Koeffler, H.P. (1999) "Loss of p73 gene expression in leukemia/lymphomas due to hypermethylation", Blood 94, 1113–1120.
  • Agirre, X., Vizmanos, J.L., Calazans, M.J., Garcia-Delgado, M., Larrayoz, M.J. and Novo, F.J. (2003) "Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients", Oncogene, In press.
  • Issa, J.P., Zehnbauer, B.A., Kaufmann, S.H., Biel, M.A. and Baylin, S.B. (2000) "HIC1 hypermethylation is a late event in hematopoietic neoplasms", Cancer Res. 57, 1678–1681.
  • Melki, J.R., Vincent, P.C., Brown, R.D. and Clark, S.J. (2000) "Hypermethylation of E-Cadherin in leukemia", Blood 95, 3208–3213.
  • Roman-Gomez, J., Castillejo, J.A., Jimenez, A., Cervantes, F., Boque, C., Hermosin, L., Leon, A., Gran�ena, A., Colomer, D., Heiniger, A. and Torres, A. (2003) "Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia a correlates with pretreatment risk profile and cytogenetic response to interferon-alpha", J. Clin. Oncol., In press.
  • Roman-Gomez, J., Jimenez, A., Castillejo, J.A., Barrios, M., Heiniger, A., Torres, A (2003) "Prognostic significance of the hypermethylation profile in acute lymphoblastic leukemia", (Submitted)
  • Oka, T., Ouchida, M., Koyama, M., Ogama, Y., Takada, S., Nakatami, Y., Tanaka, T., Yoshino, T., Hayashi, K., Ohara, N., Kondo, E., Takahashi, K., Tsuchiyama, J., Tanimoto, M., Shimizu, K. and Akagi, T. (2002) "Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas", Cancer Res. 62, 6390–6394.
  • Garcia-Manero, G., Daniel, I., Smith, T.L., Kornblau, S.M., Kantarjian, H.M. and Issa, J-P. (2002) "DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia", Clin. Cancer Res. 8, 2217–2224.
  • Kuerbitz, S.J., Pahys, J., Wilson, A., Compitello, H. and Gray, T.A. (2002) "Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia", Carcinogenesis 23, 559–564.
  • Sakashita, K., Koike, K., Kinoshita, T., Shiohara, M., Kamijo, T., Taniguchi, S. and Kubota, T. (2001) "Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development", J. Clin. Investig. 108, 1195–1204.
  • Shen, L., Ahuja, N., Shen,Y.,Habib,N.A., Toyota,M., Rashid,A. and Issa, J.P. (2002) "DNA methylation and enviromental exposures in human hepatocelular carcinoma", J. Natl Cancer Inst. 94, 755–761.
  • Toyooka, S., Maruyama, R., Toyooka, K.O., McLerran, D., Furuyama, Y., Virmani, A.K., Zochbauer-Muller, S., Tsukuda, K., Sugio, K., Shimizu, N., Shimizu, K., Lee, H., Chen, C-Y., Fong, K.M., Gilcrease, M., Roth, J.A., Minna, J.D. and Gazdar, A.F. (2003) "Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer", Int. J. Cancer 103, 153–160.
  • Roman-Gomez, J., Castillejo, J.A., Torres, A. and Jimenez, A. (2002) "Hypermethylation of the p21 gene in acute lymphoblastic leukemia", Blood 100, 3433–3434.
  • Garcia-Manero, G., Bueso-Ramos, C., Daniel, J., Williamson, J., Kantarjian, H.M. and Issa, J.P. (2002) "DNA methylation patterns at relapse in adult acute lymphoblastic leukemia", Clin. Cancer Res. 8, 1897–1903.
  • Robertson, K.D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F.A. and Jones, P.A. (1999) "The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors", Nucleic Acids Res. 27, 2291–2298.
  • Melki, J.R. and Clark, S.J. (2002) "DNA methylation changes in leukaemia", Semin. Cancer Biol. 12, 347–357.
  • Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T. and Nervi, C. (2002) "Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor", Science 295, 1079–1082.
  • Rhee, I., Jair, K.W., Yen, R.W., Lengauer, C., Herman, J.G., Kinzler, K.W., Vogelstein, B., Baylin, S.B. and Schuebel, K.E. (2000) "CpG methylation is maintained in human cancer cell lacking DNMT1", Nature 404, 1003–1007.
  • Rhee, I., Bachman, K.E., Park, B., Jair, K., Yen, R.C., Schuebel, K.M., Cui, H., Feinberg, A.P., Lengauer, C. and Kinzler, K.W. (2002) "DNMT1 and DNMT3b cooperate to silence genes in human cancer cells", Nature 416, 552–556.
  • Jones, P.A. and Taylor, S.M. (1980) "Cellular differentiation, cytidine analogs and DNA methylation", Cell 20, 85–93.
  • Lubbert, M. (2000) "DNA methylation inhibitors in the treatment of leukemias, myelodisplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action", Curr. Top. Microbiol. Immunol. 249, 135–164.
  • Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. and Baylin, S.B. (1999) "Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer", Nat. Genet. 21, 103–107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.